Helix Biopharma Corp.
Period Ending Jul 31, 2011 Jul 31, 2010
Total Revenue 4,750 4,305
Cost of Revenue 1,721 1,620
Gross Profit 3,029 2,685
Operating Expenses
Research and Development 7,675 10,403
Sales, General and Admin. 8,007 5,414
Non-Recurring Items - -
Other 423 417
Operating Income (12,943) (14,004)
Income From Continuing Operations
Add'l Income/Expense Items 1,533 (454)
Earnings Before Interest and Tax (11,410) (14,458)
Interest Expense - -
Earnings Before Tax (11,410) (14,458)
Income Tax 350 45
Minority Interest - -
Equity Earnings Unconsolidated Subsidiary - -
Net Income Cont. Operations (11,760) (14,503)
Non Recurring Events
Discontinued Operations - -
Extraordinary Items - -
Effect of Accounting Changes - -
Other Items - -
Net Income (11,893) (14,048)
Preferred Stock and Other Adjustments - -
Net Income Applicable to Common Shareholders (11,893) (14,048)